Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      UPHEALTH ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS

      New UpHealth Logo (PRNewsfoto/UpHealth, Inc.)

      News provided by

      UpHealth, Inc.

      Apr 18, 2022, 06:00 ET

      Share this article

      Share this article


      • Proforma revenue of $148.9 million for the year ended December 31st, 2021, 28% proforma growth YoY
      • Gross margin of 35% for the year ended December 31st, 2021
      • Proforma adjusted EBITDA of negative $4.0 million for the year ended December 31st, 2021.
      • GAAP net loss per share of ($3.19) for the year ended December 31st, 2021, and non-GAAP net loss per share of ($0.03), excluding goodwill impairment, acquisition-related costs, and other non-recurring expenses
      • Strong balance sheet with net cash of $58.2 million on December 31st, 2021, and no projected additional cash needed
      • Successful completion of business combination with GigCapital2 and subsequent integration of six companies
      • Reorganized strategically along three business lines addressing large markets: Integrated Care Management, Virtual Care Infrastructure Businesses, and Services Added four seasoned key executives with deep industry experience 
      • Cleaned up processes, institutionalized controls, and focused the team on ongoing transformation
      • 2022 financial outlook provided
      • New CEO expected to be announced in the coming weeks

      DELRAY BEACH, Fla., April 18, 2022 /PRNewswire/ -- UpHealth, Inc. ("UpHealth" or the "Company") (NYSE: UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced financial results for the fourth quarter and full year ended Dec. 31, 2021.

      "In the third and fourth quarters of 2021, the leadership team intensified its focus on selected strategic priorities and on the organization-wide integration. We are confident that these initiatives will result in economies of scale, product offering innovations and cross-selling opportunities," said Dr. Ramesh Balakrishnan, Chief Executive Officer. "The groundwork we laid last year will come to fruition in 2022."

      "In addition, in 2021 we successfully completed the business combination with GigCapital2 and our first fiscal year-end report along with a meticulous examination of our management processes and controls. After an arduous 'clean-up' process, we've instituted additional controls and are committed to rigorous compliance."

      Dr. Balakrishnan added, "We regret that unexpected collection challenges, especially with one long-standing customer, resulted in lower-than-expected revenue and EBITDA.  We're working diligently to complete the entire collections due to the Company and are looking forward to a fiscally successful 2022."

      Fourth Quarter 2021 Financial Highlights:

      • Revenue of $33.9 million, with gross margin of 22%
      • Fourth quarter 2021 revenues were affected by one-time factors, including:
        • A decision by the Company to deploy primary care digital dispensaries to India, a primary market, rather than the Democratic Republic of Congo, in order to achieve higher and more secure operating cash flows over the life of the assets
        • Deferred recognition of $8.3 million of Integrated Care Management license revenue that the Company expects to recognize in 2022
        • Non-recognition of $7.8 million of Integrated Care Management license revenue that the Company expects to recognize in 2022
      • Segment results:
        • Integrated Care Management generated $2.5 million of revenue (7% of total revenue) with a gross margin of (169)%
        • Virtual Care Infrastructure generated $13.7 million of revenue (40% of total revenue) with a gross margin of 39%
        • Services generated $17.7 million of revenue (52% of total revenue) with a gross margin of 34%
      • Goodwill impairment of $297.9 million
      • Adjusted EBITDA for the fourth quarter was negative $12.5 million due to $3.9 million in write-offs of receivables and prepaid expenses stemming from transactions that exclusively predated the business combination and by lower revenues.

      During the fourth quarter 2021, the Company's Integrated Care Management segment provided services to a customer but did not recognize revenue associated with those services due to concerns regarding the customer's creditworthiness and also reserved $15.6 million of outstanding receivables from the customer from the second and third quarter 2021.  In addition, during the fourth quarter 2021, the Company recorded a $6 million contingent liability in cost of goods and services related to services provided by a vendor to the Integrated Care Management segment, which is payable as proceeds are collected from the customer.  As a result, fourth quarter 2021 gross margin for both the Company and its Integrated Care Management segment were significantly impacted by recognizing the cost of goods and services without recognizing the related revenue.  If the Company had not recorded the $6 million contingent liability, the Company's gross margin during the fourth quarter would have been 38% on a non-GAAP basis, and the Integrated Care Management segment's gross margin would have been 72% on a non-GAAP basis. The Company added back the total contingent liability to the vendor of $17.8 million to adjusted EBITDA since the Company is not required to pay these expenses unless and until payment is received from the customer.

      Please refer to the commentary and tables below under "Non-GAAP Financial Information."

      Fiscal Year 2021 Financial Highlights:

      • On a pro forma basis, fiscal 2021 revenues of $148.9 million, an increase of 28% versus the comparable year-ago period, with a pro forma gross margin for fiscal 2021 of 35%
      • On a GAAP basis, revenue for fiscal 2021 of $123.8 million, with a gross margin of 35%
      • Segment results:
        • Integrated Care Management generated $31.9 million of pro forma revenue (21% of pro forma total revenue) with a gross margin of 32% and $31.9 million of GAAP revenue (26% of total revenue) with a gross margin of 32%
        • Virtual Care Infrastructure generated $52.2 million of pro forma revenue (35% of pro forma total revenue) with a gross margin of 39% and $36.6 million of GAAP revenue (30% of total revenue) with a gross margin of 39%
        • Services generated $64.8 million of pro forma revenue (44% of pro forma total revenue) with a gross margin of 34% and $55.4 million of GAAP revenue (45% of total revenue) with a gross margin of 35%
      • Goodwill impairment of $297.9 million
      • Fiscal 2021 adjusted EBITDA of negative $6.5 million and pro forma adjusted EBITDA of negative $4.0 million

      As stated above, during the fourth quarter 2021, the Company's Integrated Care Management segment provided services to a customer but did not recognize revenue associated with those services due to concerns that arose regarding the customer's creditworthiness and reserved $15.6 million of outstanding receivables from the customer from the second and third quarter 2021. In addition, during the fourth quarter 2021, the Company recorded a $6 million contingent liability in cost of goods and services related to services provided by a vendor to the Integrated Care Management segment, which is payable as proceeds are collected from the customer.  As a result, fiscal year 2021 gross margin for both the Company and its Integrated Care Management segment were significantly impacted by recognizing the cost of goods and services without recognizing the related revenue.  If the Company had not recorded the $6 million contingent liability, the Company's gross margin for 2021 would have been 40% on a non-GAAP basis and 39% on a pro forma basis, and the Integrated Care Management segment's gross margin would have been 51% on both a non-GAAP and pro forma basis. The Company added back the total contingent liability to the vendor of $17.8 million to adjusted EBITDA since the Company is not required to pay these expenses unless and until payment is received from the customer.

      Please refer to the commentary and tables below under "Non-GAAP Financial Information."

      Fourth Quarter and Full-Year Business Highlights:

      • The Company closed pricing of $43.0 million public offering, net of underwriting discounts and commissions and estimated offering expenses of $3.3 million, to further strengthen balance sheet and secure capital for continued growth.
      • Martti™, the virtual care infrastructure platform in the US, continued to expand its reach across U.S. health systems with recent large wins at Yale New Haven Health, RWJ Barnabas and Ascension Health, resulting in approximately $10 million in annualized bookings.  Martti™ currently supports 168,000 encounters per month and over 26,000 video endpoints at over 2,100 healthcare locations in the US.
      • The Company recorded its largest volume of telehealth use in the US with over 7.4 million minutes of consultations in Q4, compared to 6.1 million minutes in Q2 and 4.6 million minutes in Q3 2020. 
      • The Company opened its first digitally enabled hospital in the Indian state of Nagaland. The hospital, HelloLyf HX, is the first facility of its kind and a revolutionary re-thinking of traditional hospitals with a state-of-the-art climate resilient design vetted and approved by the acclaimed Indian Institute Technology, Roorkee.
      • After successful implementation of projects in the Indian states of Rajasthan, Odisha, and West Bengal, UpHealth won a contract to set up 550+ Hellolyf CX digital dispensaries in the Indian State of Madhya Pradesh, resulting in a total of 750+ government-placed facilities across India.

      Balance Sheet and Cash Flow

      In October, UpHealth raised $43.0 million, net of underwriting discounts and commissions and estimated offering expenses of $3.3 million, from the issuance of approximately 26.5 million shares of common stock, substantially increasing the Company's free float and increasing the total number of outstanding shares to approximately 144 million. Proceeds of the equity offering are enabling UpHealth to satisfy its short-term liabilities and fund ongoing working capital and capital expenditure requirements associated with the Company's continued growth.

      Fiscal 2022 Financial Outlook

      For the year-ended December 31st, 2022, the Company is projecting:

      • Revenue between $205 and $233 million, a 38-56% growth rate,
      • Gross margins of 42% to 43%, and
      • Adjusted EBITDA of $14 to $19 million.   

      "As we successfully complete our first yearly financial reporting as a public company, UpHealth is positioned to continue to leverage its scale and differentiation in the US and globally and is focused on solid and sustained profitability. The demand for our products and services in our target markets is unprecedented, enabling us to expand systematically on a global scale. UpHealth will grow revenue substantially in the integrated care management and virtual care management business lines, while continuing the fundamental transformation process started a few quarters ago to continue building an industry leading, global healthcare enterprise", said Dr. Ramesh Balakrishnan.

      CEO transition

      The Company announced on April 12, 2022, that a search is underway for a new CEO. The company expects to announce the new appointment in the coming weeks. Until that time, the current CEO, Dr. Ramesh Balakrishnan, will remain in place. Thereafter, he will transition to a different role in the company.

      About UpHealth Inc.

      UpHealth is a global digital health company that delivers digital-first technology, infrastructure and services to dramatically improve how healthcare is delivered and managed. The UpHealth platform creates digitally enabled "care communities" that improve access and achieve better patient outcomes at lower cost, through digital health solutions and interoperability tools that serve patients wherever they are, in their native language. UpHealth's clients include global governments, health plans, healthcare providers and community-based organizations. For more information, please visit https://uphealthinc.com and follow us at @UpHealthInc on Twitter and UpHealth Inc on LinkedIn.

      Forward-Looking Statements

      This press release contains forward-looking statements within the meaning of U.S. federal securities laws. Such forward-looking statements include, but are not limited to, the financial statements of UpHealth, its product offerings and developments and reception of its product by customers, its expectations, hopes, beliefs, intentions, plans, prospects or strategies regarding the future revenue and the business plans of UpHealth's management team, and the expected timeframe for conclusion of the search for a new CEO. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on certain assumptions and analyses made by the management of UpHealth in light of their respective experience and perception of historical trends, current conditions, and expected future developments and their potential effects on UpHealth as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting UpHealth will be those anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including the mix of services utilized by UpHealth's customers and such customers' needs for these services, market acceptance of new service offerings, the ability of UpHealth to expand what it does for existing customers as well as to add new customers, that UpHealth will have sufficient capital to operate as anticipated, the impact that the novel coronavirus and the illness, COVID-19, that it causes, as well as government responses to deal with the spread of this illness and the reopening of economies that have been closed as part of these responses, may have on UpHealth's operations, the demand for UpHealth's products, global supply chains and economic activity in general, and whether a candidate selected by the Board for the CEO role accepts an offer. Should one or more of these risks or uncertainties materialize or should any of the assumptions being made prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws.

      UPHEALTH, INC.

      CONSOLIDATED BALANCE SHEETS

      (In thousands, except per share amounts, unaudited)






      December 31, 2021


      December 31, 2020

      ASSETS

      Current assets:




           Cash and cash equivalents

      $                      58,192


      $                        1,839

           Restricted cash

      18,609


      530

           Accounts receivable, net

      22,761


      6,703

           Inventories

      2,928


      117

           Due from related parties

      40


      —

           Prepaid expenses and other current assets

      4,217


      3,501

                Total current assets

      106,747


      12,690

      Property, plant and equipment, net of accumulated depreciation of $4,741 and $3 at December 31, 2021 and 2020, respectively.

      56,072


      151

      Intangible assets, net of accumulated amortization of $12,350 and $318 at December 31, 2021 and 2020, respectively.

      115,313


      27,782

      Goodwill

      284,268


      164,194

      Deferred tax asset

      —


      335

      Equity method investments

      —


      57,214

      Other assets

      6,907


      24

                Total assets

      $                    569,307


      $                    262,390

      LIABILITIES AND STOCKHOLDERS' EQUITY

      Current liabilities:




           Accounts payable

      $                      13,604


      $                        2,680

           Accrued expenses

      36,084


      8,482

           Deferred revenue

      2,649


      397

           Due to related party

      47


      70

           Income tax payable

      739


      673

           Related-party long-term debt, current

      657


      39

           Long-term debt, current

      22,093


      22,531

           Forward share purchase liability

      18,051


      —

           Other current liabilities

      2,780


      —

                Total current liabilities

      96,704

      —

      34,872

      Related-party long-term debt, noncurrent

      331


      381

      Long-term debt, noncurrent

      98,417


      344

      Deferred tax liabilities

      28,281


      6,072

      Warrant liabilities, noncurrent

      252


      —

      Derivative liability, noncurrent

      7,977


      —

      Other long-term liabilities

      3,502


      —

                Total liabilities

      235,464


      41,669

      Stockholders' Equity




      Preferred stock, $0.0001 par value, 1,000 shares authorized; none issued or outstanding at December 31, 2021 and 2020, respectively.

      —


      —

      Common stock, $0.0001 par value, 300,000 shares authorized, 144,279 and 70,021 issued and outstanding at December 31, 2021 and 2020, respectively.

      14


      7

      Additional paid in capital

      665,461


      222,900

      Accumulated deficit

      (343,209)


      (2,186)

      Accumulated other comprehensive loss

      (3,802)


      —

                Total UpHealth, Inc., stockholders' equity

      318,464


      220,721

      Noncontrolling interests

      15,379


      —

                Total stockholders' equity

      333,843


      220,721

                     Total liabilities and stockholders' equity

      $                    569,307


      $                    262,390

      UPHEALTH, INC.

      CONSOLIDATED STATEMENTS OF OPERATIONS

      (In thousands, except per share amounts)





      Three Months Ended December 31,

      Year Ended December 31,


      2021

      2020


      2021


      2020

      Revenue:







           Services

      $                    24,660

      $                      1,664


      $                    70,223


      $                    1,664

           Licenses and subscriptions

      1,757

      3,304


      25,516


      3,304

           Products

      7,488

      428


      28,056


      428

                Total revenue

      33,905

      5,396


      123,795


      5,396

      Cost of goods and services:


      —





           Services

      14,869

      365


      41,366


      365

           License and subscriptions

      6,163

      724


      19,183


      724

           Products

      5,555

      94


      19,659


      94

                Total cost of goods and services

      26,587

      1,183


      80,208


      1,183

      Gross margin

      7,318

      4,213


      43,587


      4,213

      Operating expenses:







           Sales and marketing

      3,605

      —


      9,275


      —

           Research and development

      1,543

      874


      7,302


      874

           General and administrative

      35,282

      3,462


      57,763


      4,945

           Depreciation and amortization

      5,548

      320


      13,044


      320

           Stock-based compensation

      638

      —


      1,048


      —

           Lease abandonment expenses

      —

      —


      915


      —

           Goodwill impairment

      297,930

      —


      297,930


      —

           Acquisition, integration and transformation costs

      (277)

      —


      36,289


      —

                Total operating expenses

      344,269

      4,656


      423,566


      6,139

      Loss from operations

      (336,951)

      (443)


      (379,979)


      (1,926)

      Other income:







           Interest expense

      (5,756)

      (134)


      (19,516)


      (134)

           Gain on consolidation of equity method investment

      —

      —


      640


      —

           Gain on fair value of derivative liability

      3,961

      —


      53,846


      —

           Gain on fair value of warrant liabilities

      147

      —


      1,595


      —

           Gain on extinguishment of debt

      —

      —


      151


      —

           Other income, net, including interest income

      450

      4


      490


      4

                Total other income (expense)

      (1,198)

      (130)


      37,206


      (130)

      Loss before income tax benefit (expense)

      (338,149)

      (573)


      (342,773)


      (2,056)

      Income tax benefit (expense)

      2,080

      (50)


      2,437


      (50)

      Loss before loss from equity method investment

      (336,069)

      (624)


      (340,336)


      (2,107)

      Loss from equity method investment

      —

      (80)


      (561)


      (80)

      Net loss

      (336,069)

      (703)


      (340,897)


      (2,186)

      Less: net income (loss) attributable to noncontrolling interests

      (21)

      —


      126


      —

      Net loss attributable to UpHealth, Inc.

      $                (336,048)

      $                        (703)


      $                (341,023)


      $                   (2,186)

      Net loss per share attributable to UpHealth, Inc.:







           Basic

      $                       (2.36)

      $                       (0.01)


      $                       (3.19)


      $                     (0.04)

           Diluted

      $                       (2.36)

      $                       (0.01)


      $                       (3.19)


      $                     (0.04)

      Weighted average shares outstanding:







           Basic

      142,141

      59,267


      107,028


      52,348

           Diluted

      142,141

      59,267


      107,028


      52,348

      UPHEALTH, INC.

      CONSOLIDATED STATEMENT OF CASH FLOWS

      (In thousands)




      Year Ended December 31,


      2021


      2020

      Operating activities:




           Net loss

      $                    (340,897)


      $                        (2,186)

           Adjustments to reconcile net loss to net cash used in operating activities:




                Depreciation and amortization

      16,768


      321

                Amortization of debt issuance costs and discount on convertible debt

      8,882


      —

                Stock-based compensation

      1,048


      —

                Provision for bad debt expense

      18,617


      —

                Gain on extinguishment of debt

      (151)


      —

                Loss from equity method investment

      561


      80

                Gain on consolidation of equity method investment

      (640)


      —

                Gain on fair value of warrant liabilities

      (1,595)


      —

                Gain on fair value of convertible derivative

      (53,846)


      —

                Loss on disposal of property and equipment

      876


      —

                Deferred income taxes

      (2,406)


      (623)

                Impairment of goodwill

      297,930


      —

           Changes in operating assets and liabilities, net of effects of acquisitions:




                Accounts receivable

      (26,746)


      (1,955)

                Inventories

      200


      (17)

                Prepaid expenses and other current assets

      (6,941)


      (460)

                Accounts payable and accrued expenses

      23,019


      3,332

                Income taxes payable

      —


      673

                Deferred revenue

      1,942


      (303)

                Due to related parties

      1


      —

                Other current liabilities

      561


      —

                     Net cash used in operating activities

      (62,817)


      (1,139)

      Investing activities:




           Purchases of property and equipment

      (3,723)


      —

           Due to related parties

      497


      —

           Net cash acquired in acquisition of businesses

      3,969


      3,508

                     Net cash provided by investing activities

      743


      3,508

      Financing activities:




           Proceeds from merger and recapitalization transaction

      83,909


      —

           Proceeds from convertible debt

      164,500


      —

           Repayments of debt

      (42,645)


      —

           Payments of debt issuance costs

      (8,100)


      —

           Proceeds from Provider Relief Funds

      506


      —

           Payments of seller notes

      (99,207)


      —

           Payments of capital lease obligations

      (2,173)


      —

           Proceeds from equity offering

      42,962


      —

           Net proceeds from exercise of common stock options

      319


      —

           Deconsolidation of variable interest entity

      —


      —

           Payment of amount due to member

      (4,200)


      —

                     Net cash provided by financing activities

      135,871


      —

      Effect of exchange rate changes on cash, cash equivalents, and restricted cash

      635


      —

      Net increase in cash, cash equivalents, and restricted cash

      74,432


      2,369

      Cash, cash equivalents, and restricted cash, beginning of period

      2,369


      —

      Cash, cash equivalents, and restricted cash, end of period

      $                       76,801


      $                         2,369

      Supplemental cash flow information:




           Cash paid for interest, net of amounts capitalized

      $                         9,799


      $                             —

      Non-cash investing and financing activity:




           Issuance of common stock for debt conversion

      1,879


      —

           Property and equipment acquired through capital lease and vendor financing arrangements

      3,469


      —

           Issuance of common stock and promissory note to consummate TTC business combination

      48,233


      —

           Issuance of common stock and promissory note to consummate Glocal business combination

      132,122


      —

           Issuance of common stock and promissory note to consummate Innovations business combination

      170,378


      —

           Issuance of common stock and promissory note to consummate Cloudbreak business combination

      106,298


      —

           Issuance of common stock and promissory notes to consummate Thrasys business combinations

      —


      167,435

           Issuance of common stock and promissory notes to consummate BHS business combinations

      —


      15,770

           Issuance of common stock and promissory note for investment in unconsolidated entity

      —


      57,294

      Reconciliation of cash, cash equivalents, and restricted cash:




           Cash and cash equivalents

      58,192


      1,839

           Restricted cash

      18,609


      530

                     Total cash, cash equivalents, and restricted cash

      $                       76,801


      $                         2,369

       Non-GAAP Financial Information

      This press release includes financial measures that are not calculated in accordance with U.S. generally accepted accounting principles (GAAP). To supplement UpHealth's condensed consolidated financial statements presented in accordance with GAAP, UpHealth presents investors with non-GAAP financial measures, including pro forma revenue, pro forma gross margin, and adjusted EBITDA.

      • Pro forma revenue consists of GAAP revenue and revenue from UpHealth's subsidiaries prior to their acquisition.
      • Pro forma gross margin consists of GAAP gross margin and gross margin from UpHealth's subsidiaries prior to their acquisition.
      • Adjusted EBITDA consists of net income (loss) attributable to UpHealth, Inc., excluding depreciation and amortization; stock-based compensation; lease abandonment expenses; goodwill impairment; contingent liabilities; acquisition, integration, and transformation costs; other income (expense); income tax benefit (expense); income (loss) from equity method investment; net income (loss) attributable to noncontrolling interests; and other non-recurring charges to GAAP net income (loss) attributable to UpHealth, Inc. Other non-recurring charges to GAAP net income (loss) attributable to UpHealth, Inc. may include transaction expenses in connection with capital raising transactions (whether debt, equity or equity-linked) and acquisitions, whether or not consummated, purchase price adjustments, the cumulative effect of a change in accounting principles, or other expenses determined to be non-recurring.
      • Non-GAAP net income (loss) per share attributable to UpHealth, Inc. consists of GAAP net income (loss) attributable to UpHealth, Inc., excluding acquisition, integration and transformation costs, lease abandonment expenses, and goodwill impairment from the consolidated statements of operations, as well as other operating expenses considered to be non-recurring during the period, divided by weighted average shares outstanding for the period.

      UpHealth believes that the presentation of these non-GAAP financial measures provides important supplemental information to management and investors regarding financial and business trends relating to UpHealth's financial condition and results of operations. Management believes that the items described above provide an additional measure of UpHealth's operating results and facilitates comparisons of UpHealth's core operating performance against prior periods and business model objectives. This information is provided to investors in order to facilitate additional analyses of past, present, and future operating performance and as a supplemental means to evaluate UpHealth's ongoing operations. UpHealth believes that these non-GAAP financial measures are useful to investors in their assessment of UpHealth's operating performance.

      Pro forma revenue, pro forma gross margin and adjusted EBITDA are not calculated in accordance with GAAP, and should be considered supplemental to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. You should not consider these measures in isolation or as a substitute for analysis of UpHealth's results as reported under GAAP. UpHealth compensates for these limitations by prominently disclosing GAAP financial measures and providing investors with reconciliations from UpHealth's GAAP operating results to the non-GAAP financial measures for the relevant periods.

      The accompanying tables provide more details on the GAAP financial measures that are most directly comparable to the non-GAAP financial measures described above and the related reconciliations between these financial measures.

      UPHEALTH, INC.

      RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (1)

      (In thousands)




      Three Months Ended
      December 31, 2021


      GAAP

      Revenue

      $                       33,905



      Gross margin

      22%



      Net loss attributable to UpHealth, Inc.

      $                   (336,048)

           Net loss attributable to noncontrolling interests

      (21)

      Net loss

      (336,069)

           Other expense

      1,198

           Income tax benefit

      (2,080)

      Loss from operations

      (336,951)

           Depreciation and amortization

      6,995

           Stock-based compensation

      638

           Contingent liability (4)

      17,820

           Acquisition, integration and transformation costs, lease abandonment expenses,
                goodwill impairment, and non-recurring expenses (5)

      298,961

      Adjusted EBITDA

      $                     (12,537)


      Year Ended December 31, 2021


      GAAP


      Adjustments (2)


      Pro Forma (3)

      Revenue

      $                     123,795


      $           25,082


      $         148,877







      Gross margin

      35%


      37%


      35%







      Net loss attributable to UpHealth, Inc.

      $                   (341,023)


      $            (4,317)


      $        (345,340)

           Net loss attributable to noncontrolling interests

      126


      28


      154

      Net loss

      (340,897)


      (4,289)


      (345,186)

           Other expense

      (37,206)


      (1,171)


      (38,377)

           Income tax expense

      (2,437)


      (99)


      (2,536)

           Loss from equity method investment

      561


      —


      561

      Loss from operations

      (379,979)


      (5,559)


      (385,538)

           Depreciation and amortization

      16,768


      2,729


      19,497

           Stock-based compensation

      1,048


      —


      1,048

           Contingent liability (4)

      17,820


      —


      17,820

           Acquisition, integration and transformation costs, lease abandonment expenses,
                goodwill impairment, and non-recurring expenses (5)

      337,881


      5,302


      343,183

      Adjusted EBITDA

      $                       (6,462)


      $             2,472


      $            (3,990)

      (1)

      See Non-GAAP Financial Information section for definitions of our non-GAAP financial measures.

      (2)

      Amounts reflect operating activity of UpHealth and subsidiaries during the period prior to each subsidiary's acquisition date, if acquired during the period.

      (3)

      Amounts reflect operating activity of UpHealth and subsidiaries during the period, as if acquired at the beginning of the period.

      (4)

      Amounts reflect contingent liability to be paid only if certain fully-reserved receivables are collected.

      (5)

      Amounts reflect acquisition, integration and transformation costs, lease abandonment expenses, and goodwill impairment from the consolidated statements of operations, as well as other operating expenses considered to be non-recurring during the period.

      UPHEALTH, INC.

      RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (1)

      (In thousands)








      Three Months Ended
      December 31, 2021


      Year Ended December 31, 2021

      Net loss per share attributable to UpHealth, Inc. - GAAP


      $                                           (2.36)


      $                                           (3.19)

      Acquisition, integration and transformation costs, lease abandonment expenses,
      goodwill impairment, and non-recurring expenses (2)


      2.10


      3.16

      Net loss per share attributable to UpHealth, Inc. - Non-GAAP


      $                                           (0.26)


      $                                           (0.03)

      (1)

      See Non-GAAP Financial Information section for definitions of our non-GAAP financial measures.

      (2)

      Amounts reflect acquisition, integration and transformation costs, lease abandonment expenses, and goodwill impairment from the consolidated statements of operations, as well as other operating expenses considered to be non-recurring during the period, divided by weighted average shares outstanding for the period.

      UPHEALTH, INC.

      SEGMENT INFORMATION AND RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (1)

      (In thousands)







      Three Months Ended December 31, 2021



      Year Ended December 31, 2021


      GAAP



      GAAP


      Adjustments (2)


      Pro Forma (3)

      Revenue:









           Integrated care management (4)

      $                                                              2,460



      $     31,886


      $                         —


      $                31,886

           Virtual care infrastructure (5)

      13,729



      36,569


      15,604


      52,242

           Services (6)

      17,716



      55,340


      9,477


      64,817

                     Total

      $                                                            33,905



      $   123,795


      $                  25,081


      $              148,945











      Three Months Ended December 31, 2021



      Year Ended December 31, 2021


      GAAP



      GAAP


      Adjustments (2)


      Pro Forma (3)

      Gross Margin:









           Integrated care management (4)

      $                                                           (4,167)



      $     10,316


      $                         —


      $                10,316

           Virtual care infrastructure (5)

      5,385



      14,156


      6,096


      20,252

           Services (6)

      6,100



      19,115


      3,157


      22,272

                     Total

      $                                                              7,318



      $     43,587


      $                    9,253


      $                52,840











      Three Months Ended December 31, 2021



      Year Ended December 31, 2021


      GAAP



      GAAP


      Adjustments (2)


      Pro Forma (3)

      Gross Margin %:









           Integrated care management (4)

      (169)%



      32%


      n/a


      32%

           Virtual care infrastructure (5)

      39%



      39%


      39%


      39%

           Services (6)

      34%



      35%


      33%


      34%

                     Total

      22%



      35%


      37%


      35%












      As of December 31, 2021



      GAAP

      Total Assets:



           Integrated care management (4)


      $                                       156,106

           Virtual care infrastructure (5)


      217,668

           Services (6)


      127,114

           Corporate (7)


      68,419

                     Total


      $                                       569,307

      (1)

      See Non-GAAP Financial Information section for definitions of our non-GAAP financial measures.



      (2)

      Amounts reflect operating activity of UpHealth and subsidiaries during the period prior to each subsidiary's' acquisition date, if acquired during the period.



      (3)

      Amounts reflect operating activity of UpHealth and subsidiaries during the period, as if acquired at the beginning of the period.




      Segment Information




      Our business is organized into three operating business segments:




           Integrated Care Management—through our Thrasys subsidiary;




           Virtual Care Infrastructure—through our Glocal and Cloudbreak subsidiaries; and




           Services—through our Innovations,  BHS and TTC subsidiaries.




      The reportable segments are consistent with how management views our services and products and the financial information reviewed by the chief operating decision makers. We manage our businesses as components of an enterprise for which separate information is available and is evaluated regularly by the chief operating decision makers in deciding how to allocate resources and assess performance.





      (4)

      In the Integrated Care Management segment, we provide our customers with an advanced, comprehensive, and extensible technology platform, marketed under the umbrella "SyntraNetTM" to manage health, quality of care, and costs, especially for individuals with complex medical, behavioral health, and social needs.



      (5)

      In the Virtual Care Infrastructure segment, we provide technology and process-based healthcare platforms providing our customers comprehensive primary care, specialty consultations, and translation services, through telemedicine, Digital Dispensaries, and technology-based hospital centers.



      (6)

      In the Services segment, we provide custom compounded medications for the unique needs of every patient and prescriber. We are a full-service pharmacy filling prescriptions from our inventory of compounded medications, as well as drugs purchased from manufacturers. Additionally, we provide inpatient and outpatient substance abuse and mental health treatment services for individuals with drug and alcohol addiction and other behavioral health issues. We offer a complete continuum of care from detoxification services, residential care, partial hospitalization programs, and intensive outpatient and outpatient programs.



      (7)

      In the Corporate segment, we perform executive, administrative, finance, human resources, legal, and information technology services for UpHealth, Inc. and for its subsidiaries, managed in a corporate shared services environment. Since they are not the responsibility of segment operating management, they are not allocated to the operating segments and instead reported within Corporate.

      UPHEALTH, INC.

      RECONCILIATION OF NON-GAAP FINANCIAL MEASURES TO GUIDANCE (1)

      (in millions, unaudited)




      Full Year 2022 Guidance


      Low


      High

      Loss from operations

      $                                          (4)


      $                                          (2)

      Depreciation and amortization

      11


      13

      Stock-based compensation

      7


      8

      Adjusted EBITDA

      $                                          14


      $                                          19





      (1) See Non-GAAP Financial Information section for definitions of our non-GAAP financial measures.

      SOURCE UpHealth, Inc.

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.